Polar Capital LLP boosted its position in shares of Becton Dickinson and Co. (NYSE:BDX) by 565.8% during the second quarter, according to its most recent filing with the SEC. The fund owned 105,000 shares of the company’s stock after buying an additional 89,230 shares during the period. Polar Capital LLP’s holdings in Becton Dickinson and were worth $17,807,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Hartford Investment Management Co. boosted its stake in Becton Dickinson and by 0.9% in the second quarter. Hartford Investment Management Co. now owns 60,471 shares of the company’s stock worth $10,255,000 after buying an additional 563 shares in the last quarter. Cullen Frost Bankers Inc. boosted its stake in shares of Becton Dickinson and by 0.4% in the second quarter. Cullen Frost Bankers Inc. now owns 84,551 shares of the company’s stock worth $14,339,000 after buying an additional 356 shares during the period. Confluence Investment Management LLC boosted its stake in shares of Becton Dickinson and by 4.2% in the second quarter. Confluence Investment Management LLC now owns 67,819 shares of the company’s stock worth $11,501,000 after buying an additional 2,715 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Becton Dickinson and by 13.9% in the second quarter. Bank of New York Mellon Corp now owns 2,395,262 shares of the company’s stock worth $406,211,000 after buying an additional 291,429 shares during the period. Finally, Bourgeon Capital Management LLC boosted its stake in shares of Becton Dickinson and by 1.3% in the second quarter. Bourgeon Capital Management LLC now owns 29,265 shares of the company’s stock worth $4,963,000 after buying an additional 370 shares during the period. Institutional investors and hedge funds own 82.30% of the company’s stock.

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Becton Dickinson and Co. (NYSE:BDX) traded down 2.99% during trading on Friday, reaching $170.36. The company’s stock had a trading volume of 1,400,498 shares. The stock has a market cap of $36.27 billion, a price-to-earnings ratio of 37.94 and a beta of 1.04. The firm has a 50 day moving average price of $173.95 and a 200-day moving average price of $171.84. Becton Dickinson and Co. has a 52-week low of $129.50 and a 52-week high of $181.76.

Becton Dickinson and (NYSE:BDX) last issued its quarterly earnings results on Thursday, November 3rd. The company reported $2.12 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.09 by $0.03. Becton Dickinson and had a return on equity of 24.44% and a net margin of 7.82%. The company had revenue of $3.23 billion for the quarter, compared to analyst estimates of $3.22 billion. During the same quarter last year, the company posted $1.94 EPS. The company’s revenue for the quarter was up 5.6% compared to the same quarter last year. On average, analysts expect that Becton Dickinson and Co. will post $9.50 earnings per share for the current year.

BDX has been the topic of a number of analyst reports. Citigroup Inc. cut Becton Dickinson and from a “neutral” rating to a “sell” rating and lowered their price target for the company from $167.00 to $165.00 in a research report on Friday, September 23rd. Argus reiterated a “buy” rating and issued a $185.00 price target on shares of Becton Dickinson and in a research report on Friday, October 21st. Zacks Investment Research upgraded Becton Dickinson and from a “hold” rating to a “buy” rating and set a $200.00 price target on the stock in a research report on Wednesday. Jefferies Group reiterated a “buy” rating on shares of Becton Dickinson and in a research report on Friday, August 5th. Finally, Cowen and Company reiterated an “outperform” rating and issued a $185.00 price target on shares of Becton Dickinson and in a research report on Tuesday, August 16th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $175.39.

In other news, insider Stephen Sichak sold 10,352 shares of Becton Dickinson and stock in a transaction on Friday, November 4th. The stock was sold at an average price of $176.10, for a total value of $1,822,987.20. Following the transaction, the insider now owns 26,892 shares in the company, valued at approximately $4,735,681.20. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Linda M. Tharby sold 11,704 shares of Becton Dickinson and stock in a transaction on Tuesday, September 6th. The shares were sold at an average price of $177.27, for a total value of $2,074,768.08. Following the completion of the transaction, the insider now owns 22,146 shares in the company, valued at approximately $3,925,821.42. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Receive News & Stock Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related stocks with our FREE daily email newsletter.